Lactobacillus paracasei strain
US-12152232-B2 · Nov 26, 2024 · US
US9603880B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-9603880-B2 |
| Application number | US-201414784064-A |
| Country | US |
| Kind code | B2 |
| Filing date | Apr 16, 2014 |
| Priority date | Apr 17, 2013 |
| Publication date | Mar 28, 2017 |
| Grant date | Mar 28, 2017 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
A composition containing a Lactobacillus pentosus TUA4337L strain (accession number: NITE BP-1479), characterized in that the strain has proliferation ability in the small intestines and/or the large intestine, and preferably the small intestines, after having survived in the intestinal tract. Since the composition of the present invention contains lactic acid bacteria having proliferation ability in the intestinal tract, when ingested in the body, the lactic acid bacteria survive to the intestinal tract and proliferate, whereby the fat absorption can be blocked, and the weight gains can be blocked, so that the composition can be suitably used for the purposes of dieting effects.
Opening claim text (preview).
The invention claimed is: 1. A method of blocking fat absorption, comprising: administering a composition comprising a Lactobacillus pentosus TUA4337L strain (accession number: NITE BP-1479) to an individual in need of blocking fat absorption, in an amount effective to block fat absorption in the individual. 2. A method of ameliorating obesity, comprising: administering a composition comprising a Lactobacillus pentosus TUA4337L strain (accession number: NITE BP-1479) to an individual in need of amelioration of obesity, in an amount effective to ameliorate obesity. 3. A method of blocking weight gain, comprising: administering a composition comprising a Lactobacillus pentosus TUA4337L strain (accession number: NITE BP-1479) to an individual in need of blocking weight gain, in an amount effective to block weight gain.
Anorexiants; Antiobesity agents · CPC title
Lactobacilli, e.g. L. acidophilus or L. brevis · CPC title
Probiotics · CPC title
fermented (fermented nut meats or seeds A23L25/40; fermented milk preparations A23C9/12; addition of bacteria for nutritional purposes A23L33/135) · CPC title
Bacteria or derivatives thereof, e.g. probiotics · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.